๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Mangalore
Clinical trial register · India

Clinical Trials in Mangalore

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 1123 matching records held by the registry are in this view. Synced 21 Sep 2026, 03:16 UTC
1123
Studies in scope
all four open statuses
610
Recruiting now
open to new participants
222
Lead sponsors
across recruiting studies
Top sites
New Delhi 332 Mumbai 259 Hyderabad 237 Bangalore 193 Pune 189
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Novartis Pharmaceuticals6 Bristol-Myers Squibb3 Pfizer2 Eli Lilly and Company2 Biohaven Therapeutics Ltd.2
Site location
New Delhi332 Mumbai259 Hyderabad237 Bangalore193 Pune189
All 274 locations
Target enrolment
to
27 of 1123 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Not yet open
Prucalopride for Cognitive Functioning in Schizophrenia
NCT06474286Schizophrenia
University of Pittsburgh
Not applicable
34
Mangalore
2027-05-31
Recruiting
A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India
NCT07685769Acute Treatment of Migraine
Pfizer
Phase 4
60
Bangalore, Mangalore
2026-07-24
Recruiting
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
NCT07517263Cardiovascular Disease and Lipoprotein(a)
Novartis Pharmaceuticals
Phase 3
5,700
Guntur, Ahmedabad, Vadodara, Belagavi, Mangalore, Manipal, Kochi, Nagpur
2026-05-11
Recruiting
Parent Study Name: Pulmonary Rehabilitation to Reduce Post-Tuberculosis Morbidity (TB Pure)
NCT07164742TB - Tuberculosis, TB, TB Infection
Johns Hopkins University
Not applicable
690
Mangalore, Pune
2026-03-18
Recruiting
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
NCT07225504Secondary Progressive Multiple Sclerosis (SPMS)
Novartis Pharmaceuticals
Phase 3
1,275
Gurugram, Mangalore, Kochi, New Delhi, Chandigarh, Vellore, Hyderabad
2025-11-11
Recruiting
Study of Trastuzumab Deruxtecan, Pembrolizumab, and Platinum-based Chemotherapy in First-line HER2 Overexpressing Non-small Cell Lung Cancer
NCT06899126Non-small Cell Lung Cancer
Daiichi Sankyo
Phase 3
686
Bangalore, Bhubaneswar, Howrah, Mangalore, Pune, Surat
2025-10-24
Recruiting
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
NCT07140913Mania, Bipolar Disorder
Bristol-Myers Squibb
Phase 3
424
Mangalore, Madurai, Kolkata
2025-10-08
Active, closed
A Study of Mavacamten in Adults With Obstructive Hypertrophic Cardiomyopathy in India (ROVER)
NCT07004972Symptomatic Obstructive Hypertrophic Cardiomyopathy
Bristol-Myers Squibb
Phase 4
50
Hyderabad, Ahmedabad, Surat, Gurgaon, Belagavi, Mangalore, Ernฤkulam, Kottayam
2025-09-04
Recruiting
A Study to Assess the Long-term Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-3)
NCT06929273Bipolar Disorder Type I With Mania
Bristol-Myers Squibb
Phase 3
450
Vadodara, Belagavi, Mangalore, Kozhikode, Ludhiana, Madurai, Hyderabad, Kolkata
2025-07-18
Recruiting
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis
NCT06744920Generalized Myasthenia Gravis
Novartis Pharmaceuticals
Phase 3
180
Gurugram, Mangalore, Nashik, New Delhi, Ludhiana, Vellore, Hyderabad, Lucknow
2025-02-07
Recruiting
Innovative Multidisciplinary Strategies for Combating Severe Dengue
NCT06751836DENV Without Warning Signs, DENV with Warning Signs, Severe Dengue, Healthy Controls Group - Age and Sex-matched
Karolinska Institutet
Observational
1,400
Mangalore
2025-01-03
Active, closed
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
NCT06616194Migraine
Pfizer
Phase 3
200
Gurugram, Mangalore, Nashik, New Delhi
2024-11-15
By invitation
Long-term Safety and Tolerability of BHV-7000
NCT06443463Focal Epilepsy
Biohaven Therapeutics Ltd.
Phase 2
660
Hyderabad, Mangalore, Mumbai, Nagpur, New Delhi
2024-07-30
Recruiting
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
NCT06463587Generalized Myasthenia Gravis
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Hyderabad, Bangalore, Mangalore, Nashik, Pune
2024-06-25
Active, closed
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
NCT06309966Focal Epilepsy
Biohaven Therapeutics Ltd.
Phase 2/3
390
Hyderabad, Mangalore, Mumbai, Nagpur, New Delhi
2024-05-13
Recruiting
'Glycogen Storage Diseases (GSDs) in Indian Children- Establishing an Indian GSD (I-GSD) Registry'
NCT06396546Glycogen Storage Diseases
Institute of Liver and Biliary Sciences, India
Observational
250
Guindy, Ahmedabad, Surat, Srinagar, Bengaluru, Mangalore, Kochi, Thiruvananthapuram
2024-05-02
Recruiting
Assess Safety and Efficacy of Sovateltide in Hypoxic-ischemic Encephalopathy
NCT05514340Hypoxic-Ischemic Encephalopathy, Neonatal Asphyxia, Neonatal Encephalopathy
Pharmazz, Inc.
Phase 2
40
Mangalore, Ludhiana, Hyderabad, Kanpur
2023-09-06
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals
Phase 3
14,012
Guntur, Ahmedabad, Bangalore, Belagavi, Mangalore, Manipal, Mysore, Kochi
2023-03-09
Active, closed
CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)
NCT05681351Severe Hypertriglyceridemia
Ionis Pharmaceuticals, Inc.
Phase 3
885
Mangalore, New Delhi
2022-12-13
Active, closed
A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma
NCT05732805Melanoma, Melanoma (Skin), Melanoma Stage III, Melanoma Stage IV
Biocad
Phase 3
270
Faridabad, Mangalore, Mumbai, Nagpur, Nashik, New Delhi, Pune, Sangli
2022-08-02
Active, closed
Registry of Pediatric Orthopedic Trauma and Health Outcomes in Skeletally Immature Children
NCT04207892Long Bone Fractures
AO Innovation Translation Center
Observational
1,000
Mangalore
2022-04-05
Active, closed
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1)
NCT05147220Relapsing Multiple Sclerosis
Novartis Pharmaceuticals
Phase 3
1,000
Mangalore, Mumbai, Nashik, New Delhi, Chandigarh, Ludhiana, Lucknow, Dehradun
2021-12-16
Active, closed
Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
NCT05134441Multiple Sclerosis
Immunic AG
Phase 3
1,121
Bangalore, Mangalore, Nagpur, New Delhi, Pune, Shimla, Varanasi
2021-11-18
Active, closed
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
NCT04822181Non-alcoholic Steatohepatitis
Novo Nordisk A/S
Phase 3
1,205
Secunderabad, Surat, Gurgaon, Mangalore, Mumbai, Nagpur, Delhi, Ghitorni
2021-04-01
Active, closed
A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine
NCT04616326Chronic Migraine
Eli Lilly and Company
Phase 3
312
Ahmedabad, Gurugram, Kanpur, Mangalore, Nagpur, New Delhi, Pune
2020-11-25
Rows per page Showing 1–25 of 27
1 2 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 September 2026. https://priyalifescience.com/clinical-trials-india/city/mangalore

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.